Stock listing

NASDAQ:ATRS Antares Pharma Inc Stock

Follow Antares Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ATRS

$5.59 USD

Close on May 24, 2022 · No longer trades

Jan 29, 1999 to last close +179.5% · monthly closes, Jan 29, 1999 – May 24, 2022
Lowest – highest close
$0.32 – $6.38 USDSince Jan 29, 1999 · lowest Dec 19, 2008 · highest Apr 28, 1999

Delisted NASDAQ:ATRS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ATRS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Antares Pharma Inc on 6ix

Decks
36 decks · latest Mar 7, 2022

Decks

DeckKindSlidesDate
Investor Presentation (March 2022)Investor deck25 slidesMar 7, 2022
Investor Presentation (January 2022)Investor deck25 slidesJan 12, 2022
Investor Presentation (August 2021)Investor deck28 slidesAug 18, 2021
Investor Presentation (June 2021)Investor deck27 slidesJun 1, 2021
Investor Presentation (March 2021)Investor deck28 slidesMar 5, 2021
Investor Presentation (January 2021)Investor deck28 slidesJan 11, 2021
Investor Presentation (November 2020)Investor deck31 slidesNov 12, 2020
Investor Presentation (March 2020)Investor deck27 slidesMar 4, 2020
Investor Presentation (January 2020)Investor deck27 slidesJan 13, 2020
Investor Presentation (September 2019)Investor deck22 slidesSep 10, 2019
All 36 decks
DeckKindSlidesDate
Raymond James Life Sciences & MedTech Conference 2019Conference24 slidesJun 18, 2019
Raymond James & Associates 40th Annual Institutional Investors Conference 2019Conference24 slidesMar 5, 2019
Investor Presentation (January 2019)Investor deck24 slidesJan 7, 2019
Jefferies 2018 Global Healthcare ConferenceConference24 slidesNov 15, 2018
Ladenburg Thalmann 2018 Healthcare ConferenceConference26 slidesOct 2, 2018
H.C. Wainwright 20th Annual Global Investment Conference (September 2018)Conference26 slidesSep 6, 2018
Jefferies 2018 Healthcare ConferenceConference23 slidesJun 5, 2018
Deutsche Bank Securities 43rd Annual Health Care Conference 2018Conference17 slidesMay 9, 2018
Raymond James & Associates 39th Annual Institutional Investors Conference (March 2018)Conference16 slidesMar 5, 2018
Investor Presentation (August 2017)Investor deck20 slidesAug 9, 2017
Jefferies 2017 Healthcare ConferenceConference16 slidesJun 8, 2017
Cowen and Company 37th Annual Healthcare Conference (March 2017)Conference22 slidesMar 6, 2017
Investor Presentation (January 2017)Investor deck25 slidesJan 27, 2017
Ladenburg Thalmann 2016 Healthcare ConferenceConference18 slidesSep 27, 2016
Investor Presentation (September 2016)Investor deck23 slidesSep 14, 2016
Jefferies 2016 Healthcare ConferenceConference22 slidesJun 8, 2016
Cowen and Company 36th Annual Healthcare Conference 2016Conference27 slidesMar 9, 2016
34th Annual J.P. Morgan Healthcare Conference (January 2016)Conference28 slidesJan 11, 2016
Investor Presentation (May 2007)Investor deck30 slidesMay 10, 2007
Investor Presentation (May 2006)Investor deck19 slidesMay 5, 2006
Shareholder Meeting (May 2006)Shareholder meeting42 slidesMay 5, 2006
Investor Presentation (May 2006)Investor deck38 slidesMay 5, 2006
Shareholder Meeting (May 2005)Shareholder meeting51 slidesMay 3, 2005
UBS Global Life Sciences Conference 2004Conference31 slidesSep 28, 2004
Shareholder Meeting (June 2004)Shareholder meeting53 slidesJun 22, 2004
FBR 8th Annual Growth Investor Conference 2004Conference29 slidesJun 3, 2004

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Karen Smith
Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past)
Director · Mar 1, 2019 – May 24, 2022 · Past
Peter Greenleaf
Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); BioDelivery Sciences International Inc (Director · May 21, 2018 – Mar 22, 2022 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past); Sucampo Pharmaceuticals Inc (Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past)
Director · Dec 12, 2018 – May 24, 2022 · Past
Jack E Stover
Other companies: TransCode Therapeutics, Inc. (Director · Since at least Dec 19, 2025); Profusa, Inc. (Chief Executive Officer · Since at least Dec 20, 2021); Traws Pharma, Inc. (Director · Since at least May 18, 2016); PharmaCyte Biotech, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past); Interpace Biosciences, Inc. (President and CEO, Director · Aug 3, 2005 – Mar 12, 2020 · Past)
President and CEO, Director · Jan 25, 2006 – May 14, 2008 · Past
James P. Tursi
Other companies: MetaVia Inc. (Independent Director · Since at least Nov 1, 2023); Endo International PLC (Executive VP, Global R&D · Feb 24, 2022 – Jul 15, 2022 · Past); Aralez Pharmaceuticals Inc (Chief Medical Officer · Feb 5, 2016 – May 14, 2018 · Past); POZEN Inc (Chief Medical Officer · Oct 1, 2015 – Oct 1, 2015 · Past); Auxilium Pharmaceuticals Inc (Chief Medical Officer · Feb 14, 2012 – Jan 29, 2015 · Past)
EVP, Chief Medical Officer · Aug 6, 2018 – Jun 13, 2019 · Past
Anton Gueth
Other companies: Spectrum Pharmaceuticals Inc (Director · Mar 27, 2012 – Dec 19, 2012 · Past)
Director · May 10, 2007 – May 24, 2022 · Past
Kaushik J Dave
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (CEO and Interim CFO, Director · Sep 16, 2013 – Mar 14, 2017 · Past)
Executive Vice President · May 6, 2013 – Jun 3, 2013 · Past
Marvin SamsonDirector · May 22, 2013 – Jan 10, 2020 · Past
Peter L SadowskiSenior Vice President · Nov 11, 2010 – May 17, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Antares Pharma Inc.